You are here

Article metrics

Article menu
XML
Clinical/translational cancer immunotherapy
Original research
Innovative therapeutic strategy for B-cell malignancies that combines obinutuzumab and cytokine-induced killer cells

 

Online download statistics by month:

Online download statistics by month: July 2021 to September 2025

AbstractFullPdf
Jul 2021436436152
Aug 202116816867
Sep 202111611681
Oct 202111011042
Nov 202110510535
Dec 2021868629
Jan 2022626652
Feb 2022424221
Mar 2022748131
Apr 2022616429
May 2022829360
Jun 2022738434
Jul 2022515430
Aug 2022687844
Sep 2022637049
Oct 2022708129
Nov 2022818113
Dec 202273739
Jan 2023585820
Feb 2023606018
Mar 2023363726
Apr 2023272720
May 2023383819
Jun 2023343419
Jul 2023272710
Aug 2023343415
Sep 202321217
Oct 2023292914
Nov 2023262614
Dec 2023383830
Jan 2024343528
Feb 2024424227
Mar 2024393945
Apr 2024404018
May 2024999919
Jun 2024363719
Jul 2024363720
Aug 2024353467
Sep 20244343758
Oct 2024444538
Nov 2024242516
Dec 2024626429
Jan 2025535332
Feb 2025303020
Mar 2025464636
Apr 2025515117
May 2025313126
Jun 202513149
Jul 2025110
Sep 2025110
Total300930842243